Brandon L Panaro Selected Research

Therapeutics

1/2017

β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brandon L Panaro Research Topics

Disease

4	Body Weight (Weight, Body) 01/2021 - 04/2015
2	Obesity 04/2013 - 03/2011
2	Hyperphagia (Overeating) 04/2013 - 03/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Weight Gain 01/2019
1	Weight Loss (Weight Reduction) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Insulin Resistance 01/2017

Drug/Important Bio-Agent (IBA)

4	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 10/2017 - 03/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
2	LipidsIBA 01/2019 - 03/2011
2	setmelanotideIBA 10/2017 - 04/2015
2	MelanocortinsIBA 04/2013 - 03/2011
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	T Cell Transcription Factor 1IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Peptides (Polypeptides)IBA 10/2017
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2017
1	AdipokinesIBA 01/2017
1	CarbohydratesIBA 04/2013
1	Dietary Fats (Dietary Fat)IBA 03/2011
1	N-acylphosphatidylethanolamineIBA 03/2011

Therapy/Procedure

1	Therapeutics 01/2017